S6/10Social
Ebola Vaccine Trials Could Start This Year
As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a candidate vaccine could enter human trials by year-end. (Source: Bloomberg)
⚠️ This is a probabilistic forecast, not a guarantee. Accuracy is measured only on resolved scenarios; monitor confirmation indicators below.
A
Эскалация— 25% model probability
Сценарии event-driven intelligence
Horizon: 7–30 days